Poster Library

POSTER LIBRARY

Use the links below to download posters from our international meetings.

FALL SUMMIT 2022

2022 XCN AZ HF resectable NSCLC

Advancing Cannabinoid Education & Science Study

CDK4 6 inhibitors treatment use in women treated for advanced breast cancer Integrating ASCO NCODA patient centered standards in a community pharmacy

CoE MIP Poster

DeFi- A Phase 3 Trial of Nirogacestat for Progressing Desmoid Tumors (DT)

Impact of patient support program participation on treatment compliance for patients initiating ibrutinib

Lack of Management Education in the Pharmacy School Curriculum

NCCN- ASCO NCODA Standards

NCODA CAWT

NCODA GROWTH

NCODA IMW

NCODA Legislative Initiatives

NCODA Nursing Committee

NCODA OPTA

NCODA Positive Quality Interventions (PQI)

NCODA Poster PSO

NCODA PQI in Action

NCODA TSK

NCODA Utilization of PQIs and TSKs with Selinexor

Population Pharmacogenomics Analysis Highlights the Significance of Pharmacogenomic Testing in the Community Oncology Setting

Poster Trialing an Evidence based Role for Nursing- Oral Oncolytic Nurse Navigator

Retrospective Analysis of a Pharmacist-Led Dose Rounding Initiative at an Outpatient Oncology Practice

Retrospective Comparison of Patient Outcomes on Pacritinib vs Ruxolitinib

Robotics & Oncology

SDOH Poster

WE PLEDGE – All these voices combine as one, with one goal…a pledge to do the very best we can to get patients better

Covid Prevention in Adult Cancer Patients

Factors Associated with Initiation of Oral Antineoplastic Therapies in an Urban Academic Medical Center

Impact of COVID-19 Pandemic on Cancer Care Delivery in Ontario

Informal Caregiver Burnout

Teaching and Reinforcing Pharmaceutical Calculations Through an Interactive Immediate Response Learning Program

OCS 2022

Covid Prevention in Adult Cancer Patients

Factors Associated with Initiation of Oral Antineoplastic Therapies in an Urban Academic Medical Center

Impact of COVID-19 Pandemic on Cancer Care Delivery in Ontario

Informal Caregiver Burnout

Teaching and Reinforcing Pharmaceutical Calculations Through an Interactive Immediate Response Learning Program

SPRING FORUM 2023

A Case of AL Amyloid that Initially Presented as new Onset Heart Failure with Preserved Ejection Fraction

A Punch to the Gut- Antibiotics May Diminish the Therapeutic Effect of Immune Checkpoint Inhibitors

Advancing Cannabinoid Education & Science Study

Benefits of a Integrated Pharmacy Help Desk

Cancer Related Fatigue

Clinical Utility and The Role of Widespread and Broad Based Pan-Cancer Germline Testing (Outside of Current Guidelines) in Community Cancer Clinics

Comparing Acalabrutinib and Ibrutinib in the Real World- A Study of 2,509 Patients with Chronic Lymphocytic Leukemia

Defining FOXR1 Expression and Function in Cancer

Expansion Analysis of a Grassroots Oncology Organization

Expansion of Oncology Pharmacy Practice Through Bruton’s Tyrosine Kinase Inhibitor Cardiovascular Assessments

Fatalities from Tumor Lysis Syndrome (TLS) After Anti-Hyperuricemic Monotherapy – Nationally Representative, Propensity Score Matched, Retrospective Study Comparison of Rasburicase and Allopurinol

Growth of NCODA Professional Student Organization Chapters

Guideline and Standard Development for Medically Integrated Dispensing Pharmacies for Oral Anticancer Medication- ASCO_NCODA Standards

How Specialty Pharmacy Enhances The Patient Experience

If Every Patient Were the Same, Then Treatments Would Be Too

Impact of an Analytics Intervention on G-CSF Prescription Turnaround in Speciality Pharmacy

Impact of Ribociclib Dose Modifications on Overall Survival in Patients with HR+_HER2 – Advanced Breast Cancer in MONALEESA-2

Interim Analysis from ELEANOR- A Multi-national, Prospective, Non-interventional Study Among Patients with HER2+ and HR+ Early Breast Cancer Treated with Extended Adjuvant Neratinib in the Clinical Routine

K-RAS-tling with Resistance- KRASG12C Inhibitors and Strategies for Overcoming Resistance

Managing Oral Chemo Compliance

Medically Integrated Patient Assistance For Oncology

Metformin (MET) for the prevention of Alpelisib (ALP)-related Hyperglycemia (HG) in PIK3CA-mutated, Hormone Receptor-Positive (HR[+])_HER2-Negative (HER2[-]) Advanced Breast Cancer (ABC)- The METALLICA study

National Results of Utilizing the NCODA Cost Avoidance and Waste Tracker Tool- An Online Method of Identifying and Preventing Drug Waste

NCODA International Monthly Webinar

NCODA Nursing Community

NCODA Oral Oncolytics Adherence Assessment

Oncology Basics Course- On-Demand Refresher for Pharmacy Trainees

Oncology Pharmacy Technician Association (OPTA)

Pacritinib is a Potent ACVR1 Inhibitor with Significant Anemia Benefit in Patients with Myelofibrosis

Pharmacy Student Perspectives On Oncology Education

Planning for the Future- A Review of Cancer in Pregnancy and Fertil

Positive Quality Interventions (PQI)- Idea to Implementation

Positive Quality Interventions in Action

Quality of Life with Ribociclib Plus Aromatase Inhibitor vs Abemaciclib Plus Abemaciclib Plus Aromatase Inhibitor as First-Line Treatment of HR+_HER2

ROPEGINTERFERON ALFA-2B ACHIEVES PATIENT-SPECIFIC TREATMENT GOALS IN POLYCYTHEMIA VERA- A DISCUSSION OF THE FINAL RESULTS FROM THE PROUD-PV:CONTINUATION-PV STUDIES

Starting an Interprofessional PSO Chapter as a Distance Student

The Future of Combination Immunotherapy for Cancer Treatment

The Road map to success in the Value Based Care Models

The role of Social Determinant of Health (SDoH) and Health Related Social Needs (HrSN) data in addressing Cancer Health Disparities

Treatment Support Kits Supportive Care Provided for Patients

Updated Expert Consensus Recommendations for Managing Hyperglycemia and Rash in Patients With PIK3CA– Mutated, Hormone Receptor- Positive (HR+), Human Epidermal Growth Factor Receptor 2-Negative (HER2–) Advanced Breast Cancer Treated With
Alpelisib

Use of a Validated AML Composite Score Measuring Fitness and Cytogenetic Risk to Assess Outcomes in 1L AML Patients Receiving Venetoclax Plus Azacitidine in VIALE‑A

Utility of the Layer-by-layer Technique in Photodynamic Therapy to Enhance Photodynamic Efficacy

RESOURCES

Cost Avoidance Waste Tracker

Positive Quality Interventions

PQI in Action

OCE Sheets

IVE Sheets

Treatment Support Kits

PQI Podcast

Members

Member Resources

OPTA

Committees

Member Login

Events

Webinars

Spring Forum

Oncology Institute

PSO Annual Meeting

Fall Summit

JOIN NCODA

315-655-4640

P.O. Box 468
Cazenovia, NY 13035

NCODA is a 501(c)(3) Organization